ARCHIVES

Two-Week Break Balances RT Palliation, Side Effects

This article is from The Cancer Letter archive.

Vol. 33 No. 2 | February 26, 2010

Download PDF Visit The Full Archive

Related Articles

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001

UCLA, NYU, Ohio States Must Wait Longer For Comprehensive Status

November 28, 1975

Suspect Chemical Include Castor Oil, Witchhazel; Details On 38 Picked For Long Term Tests

August 5, 1977

Bush Appoints Lander To NCAB

January 24, 2003